X4 Pharmaceuticals (XFOR) Change in Inventory (2024 - 2025)
X4 Pharmaceuticals (XFOR) reported Change in Inventory of $399000.0 for Q4 2025, up 7.26% on a YoY basis from $372000.0 in Q4 2024, and down 56.15% quarter-over-quarter from $910000.0 in Q3 2025.
X4 Pharmaceuticals (XFOR) Change in Inventory (2024 - 2025) Analysis & Trends
X4 Pharmaceuticals has reported Change in Inventory for 2 years, with the latest figure at $399000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Inventory rose 7.26% year-over-year to $399000.0; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (down 41.0% YoY), and the FY2025 full-year result was $1.7 million, down 41.0% from the prior year.
- Change in Inventory for Q4 2025 stood at $399000.0, down from $910000.0 in the prior quarter.
- The five-year high for Change in Inventory was $1.6 million in Q3 2024, with the low at $81000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | X4 Pharmaceuticals | 156.06 Mn | 156.06 Mn | 2.20 Mn | 399,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 399,000.00 |
| Dec 31, 2025 | 399,000.00 |
| Sep 30, 2025 | 910,000.00 |
| Sep 30, 2025 | 910,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | 272,000.00 |
| Mar 31, 2025 | 272,000.00 |
| Dec 31, 2024 | 372,000.00 |
| Dec 31, 2024 | 372,000.00 |
| Sep 30, 2024 | 1.61 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 831,000.00 |
| Jun 30, 2024 | 831,000.00 |